Saccharomyces boulardii
Trials 23
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 33 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saccharomyces Boulardii | “Saccharomyces Boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective...” PMID 34869495 ↗ Nov 202130“Probiotics combination capsule (Bacillus Subtilis 150 mg /Clostridium Burtyricum Toa 150 mg /Saccharomyces Boulardii 113 mg) per oral, three times a day, for 8 weeks” NCT05993247 ↗ “To evaluate the efficacy of locally delivered saccharomyces boulardii on clinical and microbiological parameters in the treatment of chronic periodontitis.” NCT03516370 ↗ “A complex of 250 mg of Saccharomyces boulardii and 500 IU SOD to be assumed twice/day for 8 weeks at mealtimes” NCT04919850 ↗ “Saccharomyces boulardii + Esomeprazole + Amoxicillin + Clarithromycin” NCT03220542 ↗ “Drug: Saccharomyces boulardii” NCT03997279 ↗ |
| Known as | CNCM I-745 | “Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Bacillus clausii O/C, SIN, N/R, T) for the treatment of PAGE.” PMID 36086703 ↗ Sep 2022 |
| Known as | Florastor | “Saccharomyces Boulardii 250 MG [Florastor]” NCT06149676 ↗ |
| Known as | S. boulardii | “CONCLUSIONS: Metronidazole treatment is partially effective in SIBO, but S. boulardii in monotherapy or in combination improves the gastrointestinal outcomes in SSc.” PMID 31549334 ↗ Sep 20191“or S. boulardii (250 mg twice daily for 5 days)” PMID 26541878 ↗ Dec 2015 |
| Known as | Sac. boulardii | “The non-pathogenic yeast Saccharomyces cerevisiae var. boulardii (Sac. boulardii) is considered the most promising probiotic substance for the prevention of AAD and CDAD.” NCT01143272 ↗ |
| Known as | Saccharomyces boulardii CNCM I-745 | “Saccharomyces boulardii CNCM I-745 is a probiotic yeast that has proven efficacy for the treatment of acute gastroenteritis and antibiotic-associated diarrhea.” NCT04627337 ↗ |
| Known as | Saccharomyces cerevisiae var. boulardii | “The non-pathogenic yeast Saccharomyces cerevisiae var. boulardii (Sac. boulardii) is considered the most promising probiotic substance for the prevention of AAD and CDAD.” NCT01143272 ↗ |
| Known as | Sacchraomyces Boulardii | “Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis” NCT03516370 ↗ |
| Action | Restore | “helps to quickly restore the intestinal mucosal barrier and the gut microbiome” NCT07813182 ↗ |
| Modality | Other / unclassified | “Saccharomyces Boulardii is a probiotic yeast” NCT00543478 ↗ |
| Route | Oral | “Oral, 1 capsule twice a day, maximum 2 capsules in a 24 hour period for a maximum of 5 days” NCT00807326 ↗ |